Gambaran Umum
Clene Inc. is a biopharmaceutical company based in the United States, primarily focused on the innovation of unique therapies for neurodegenerative diseases. The company is pioneering in the development of nanotherapeutics designed to enhance cellular energetics. One of their key projects includes CNM-Au8, an investigational nanocatalyst aimed at improving the cellular bioenergetic processes critical for repairing and maintaining cellular health. The company’s approach involves a proprietary clean-surfaced nanotechnology platform that is being tested in various clinical trials for conditions such as multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis. With its uniquely positioned technology, Clene Inc. is committed to addressing complex neurodegenerative disorders by improving fundamental cellular functions.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Clene Inc. per 2025 Jun 30 adalah 0.29 MM.
- Nilai operating income untuk Clene Inc. per 2025 Jun 30 adalah -26.41 MM.
- Nilai net income untuk Clene Inc. per 2025 Jun 30 adalah -29.70 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 0.29 | -26.41 | -29.70 |
2025-03-31 | 0.35 | -27.94 | -29.07 |
2024-12-31 | 0.34 | -33.09 | -39.40 |
2024-09-30 | 0.42 | -34.37 | -36.02 |
2024-06-30 | 0.44 | -36.09 | -30.46 |
2024-03-31 | 0.62 | -39.04 | -48.81 |
2023-12-31 | 0.65 | -40.54 | -49.50 |
2023-09-30 | 0.72 | -42.28 | -40.38 |
2023-06-30 | 0.78 | -42.55 | -48.94 |
2023-03-31 | 0.55 | -45.80 | -28.33 |
2022-12-31 | 0.47 | -48.41 | -29.92 |
2022-09-30 | 0.44 | -50.79 | -24.44 |
2022-06-30 | 0.37 | -51.44 | 15.48 |
2022-03-31 | 0.54 | -51.62 | 16.66 |
2021-12-31 | 0.72 | -49.98 | -9.74 |
2021-09-30 | 0.55 | -41.88 | -13.38 |
2021-06-30 | 0.54 | -37.12 | -52.62 |
2021-03-31 | 0.35 | -27.91 | -55.09 |
2020-12-31 | 0.21 | -20.21 | -19.28 |
2020-09-30 | 0.18 | -18.61 | -24.30 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Clene Inc. pada 2025 Jun 30 adalah -3.57.
- laba per saham yang terdilusi untuk Clene Inc. pada 2025 Jun 30 adalah -3.57.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -3.57 | -3.57 |
2025-03-31 | -3.85 | -3.85 |
2024-12-31 | -5.67 | |
2024-09-30 | -5.58 | -5.58 |
2024-06-30 | -4.74 | -4.74 |
2024-03-31 | -8.27 | -8.27 |
2023-12-31 | -9.43 | |
2023-09-30 | -8.92 | -8.92 |
2023-06-30 | -13.19 | -13.19 |
2023-03-31 | -0.41 | -0.41 |
2022-12-31 | -0.46 | |
2022-09-30 | -0.39 | -0.39 |
2022-06-30 | 0.25 | 0.25 |
2022-03-31 | 0.27 | 0.27 |
2021-12-31 | -0.16 | |
2021-09-30 | -0.27 | -0.26 |
2021-06-30 | -1.34 | -1.34 |
2021-03-31 | -1.94 | -1.94 |
2020-12-31 | -1.10 | |
2020-09-30 | -0.19 | -0.20 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Clene Inc. per 2025 Jun 30 adalah -17.64 MM.
- Nilai cash from investing activities untuk Clene Inc. per 2025 Jun 30 adalah -0.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Clene Inc. per 2025 Jun 30 adalah 3.27 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -17.64 | -0.00 | 3.27 |
2025-03-31 | -19.25 | 6.25 | 1.16 |
2024-12-31 | -21.33 | 6.32 | -1.53 |
2024-09-30 | -23.63 | 0.11 | -4.08 |
2024-06-30 | -27.37 | 0.06 | -0.25 |
2024-03-31 | -28.04 | -6.15 | 37.56 |
2023-12-31 | -30.17 | -1.50 | 42.16 |
2023-09-30 | -30.71 | 7.00 | 58.55 |
2023-06-30 | -32.44 | 15.45 | 58.88 |
2023-03-31 | -35.15 | 19.08 | 21.60 |
2022-12-31 | -39.01 | -10.16 | 17.25 |
2022-09-30 | -40.90 | -13.12 | 0.86 |
2022-06-30 | -39.73 | -21.77 | 6.00 |
2022-03-31 | -38.55 | -25.65 | 29.24 |
2021-12-31 | -34.62 | -1.33 | 27.11 |
2021-09-30 | -30.83 | -0.78 | 55.30 |
2021-06-30 | -31.24 | -0.61 | 87.76 |
2021-03-31 | -24.84 | -0.57 | 66.09 |
2020-12-31 | -18.93 | -0.39 | 69.53 |
2020-09-30 | -16.48 | -0.31 | 41.32 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Clene Inc. pada 2025 Jun 30 adalah -6.99.
- p/tbv untuk Clene Inc. pada 2025 Jun 30 adalah -6.99.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -6.99 | -6.99 | |
2025-03-31 | -0.70 | -3.12 | -3.12 |
2024-12-31 | -9.67 | -9.67 | |
2024-09-30 | -1.02 | -61.88 | -61.88 |
2024-06-30 | -0.97 | 11.11 | 11.11 |
2024-03-31 | 4.08 | 4.08 | |
2023-12-31 | -0.92 | 1.74 | 1.74 |
2023-09-30 | -1.26 | 2.87 | 2.87 |
2023-06-30 | -2.43 | -42.40 | -42.40 |
2023-03-31 | -2.93 | 27.05 | |
2022-12-31 | -7.92 | -7.92 | |
2022-09-30 | -315.82 | -315.82 | |
2022-06-30 | 9.55 | 78.87 | 78.87 |
2022-03-31 | -25.37 | 19.62 | 19.62 |
2021-12-31 | -19.05 | 44.85 | 44.85 |
2021-09-30 | -8.00 | -16.25 | -16.25 |
2021-06-30 | |||
2021-03-31 | -3.40 | -5.19 | -5.19 |
2020-12-31 | -9.71 | 549.00 | 549.00 |
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Clene Inc. pada 2025 Jun 30 adalah -0.71.
- EBIT (3 tahun) / EV untuk Clene Inc. pada 2025 Jun 30 adalah -0.88.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.71 | -0.88 |
2025-03-31 | -1.26 | -1.24 |
2024-12-31 | -0.84 | -0.89 |
2024-09-30 | -0.82 | -0.86 |
2024-06-30 | -0.92 | -0.38 |
2024-03-31 | -0.94 | -0.57 |
2023-12-31 | -1.89 | -1.22 |
2023-09-30 | -1.27 | -0.75 |
2023-06-30 | -0.37 | -0.28 |
2023-03-31 | -0.32 | -0.24 |
2022-12-31 | -0.28 | -0.24 |
2022-09-30 | 0.08 | -0.04 |
2022-06-30 | 0.10 | -0.11 |
2022-03-31 | -0.05 | -0.13 |
2021-12-31 | -0.06 | -0.08 |
2021-09-30 | -0.14 | -0.07 |
2021-06-30 | ||
2021-03-31 | -0.21 | -0.10 |
2020-12-31 | -0.07 | -0.06 |
2020-09-30 |
Efektivitas Manajemen
- roa untuk Clene Inc. pada 2025 Jun 30 adalah -0.72.
- roic untuk Clene Inc. pada 2025 Jun 30 adalah -1.82.
- croic untuk Clene Inc. pada 2025 Jun 30 adalah -0.75.
- ocroic untuk Clene Inc. pada 2025 Jun 30 adalah -1.21.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.72 | -1.82 | -0.75 | -1.21 | |
2025-03-31 | -0.87 | -9.24 | -3.29 | -1.39 | -1.78 |
2024-12-31 | -0.69 | -2.69 | -1.92 | -1.46 | -1.26 |
2024-09-30 | -0.50 | -1.42 | -0.95 | -0.86 | -0.85 |
2024-06-30 | -1.22 | -1.33 | 0.09 | -0.76 | |
2024-03-31 | -1.11 | -15.29 | -1.09 | 0.23 | -0.66 |
2023-12-31 | -1.12 | -0.76 | 0.65 | -0.58 | |
2023-09-30 | -1.10 | -0.92 | 0.79 | -0.61 | |
2023-06-30 | -0.64 | -0.91 | 0.78 | -0.60 | |
2023-03-31 | -0.56 | -14.83 | -0.94 | 0.18 | -1.17 |
2022-12-31 | -0.33 | -4.30 | -1.40 | -3.05 | -2.34 |
2022-09-30 | 0.21 | 2.72 | -1.42 | -3.09 | -2.37 |
2022-06-30 | 0.23 | 0.61 | -2.20 | -1.57 | |
2022-03-31 | -0.17 | 0.60 | -1.27 | -1.40 | |
2021-12-31 | -0.20 | -39.25 | -0.27 | -0.24 | -1.05 |
2021-09-30 | -0.28 | -1.39 | -0.53 | ||
2021-06-30 | -3.99 | -52.21 | |||
2021-03-31 | -3.70 | -6.80 | |||
2020-12-31 | -1.30 | -2.38 | -2.55 | 6.68 | -2.50 |
2020-09-30 | -1.58 | -0.54 | 0.55 | -0.37 |
Gross Margins
- marjin kotor untuk Clene Inc. pada 2025 Jun 30 adalah 0.79.
- marjin bersih untuk Clene Inc. pada 2025 Jun 30 adalah -83.06.
- marjin operasi untuk Clene Inc. pada 2025 Jun 30 adalah -79.82.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.79 | -83.06 | -79.82 |
2025-03-31 | 0.80 | -115.20 | -96.76 |
2024-12-31 | 0.79 | -85.57 | -81.63 |
2024-09-30 | 0.81 | -68.90 | -81.66 |
2024-06-30 | 0.79 | -78.73 | -62.97 |
2024-03-31 | 0.81 | -75.69 | -61.99 |
2023-12-31 | 0.87 | -56.25 | -58.89 |
2023-09-30 | 0.88 | -62.43 | -54.27 |
2023-06-30 | 0.94 | -62.43 | -54.27 |
2023-03-31 | 0.95 | -51.52 | -83.28 |
2022-12-31 | 2.15 | -55.80 | -115.97 |
2022-09-30 | 2.36 | -55.80 | -115.97 |
2022-06-30 | 0.91 | 41.39 | -137.54 |
2022-03-31 | 0.60 | 30.86 | -95.59 |
2021-12-31 | -0.48 | -13.47 | -69.13 |
2021-09-30 | -0.49 | -24.20 | -75.73 |
2021-06-30 | -0.49 | -97.27 | -68.62 |
2021-03-31 | 0.28 | -157.86 | -79.96 |
2020-12-31 | 0.68 | -93.58 | -98.13 |
2020-09-30 | 0.67 | -137.27 | -105.13 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1822791 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |